Toxoplasma gondii
For years, toxoplasmosis has been known as disease mostly affecting newborns. Since immunocompromised patients (AIDS) present a high risk of reactivation of chronic toxoplasmosis this parasitic disease has gained increasing interest. Besides presenting clinical and therapeutical concepts, this volum...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1996, 1996
|
| Edition: | 1st ed. 1996 |
| Series: | Current Topics in Microbiology and Immunology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- A Population Structure of Toxoplasma gondii: Implications of Clonality
- Genetic Basis of Pathogenicity in Toxoplasmosis
- DNA Polymorphisms Associated with Murine Virulence of Toxoplasma gondii Identified by RAPD-PCR
- Biodiversity in Toxoplasma gondii
- B The Parasite: From Antigens to Genes
- The Major Surface Proteins of Toxoplasma gondii: Structures and Functions
- Toxoplasma gondii Microneme Proteins: Gene Cloning and Possible Function
- Role of Secretory Dense Granule Organelles in the Pathogenesis of Toxoplasmosis
- Serological Recognition of Toxoplasma gondii Cyst Antigens
- Toxoplasma gondii: Kinetics of Stage-Specific Protein Expression During Tachyzoite-Bradyzoite Conversion in Vitro
- Bradyzoite-Specific Genes
- C The Host: Immunogenetics and Immune Response
- Immunogenetics in Pathogenesis of and Protection Against Toxoplasmosis
- Cells and Cytokines in Resistance to Toxoplasma gondii
- Role of Macrophage-Derived Cytokines in the Induction and Regulation of Cell-Mediated Immunity to Toxoplasma gondii
- Role of Nitric Oxide-Induced Immune Suppression in Toxoplasmosis During Pregnancy and in Infection by a Virulent Strain of Toxoplasma gondii
- Cytokine Production by Human Cells after Toxoplasma gondii Infection
- Characterization of Human T Cell Clones Specific for Toxoplasma gondii
- Toxoplasma Proteins Recognized by Protective T Lymphocytes
- Immunological Control of Toxoplasma gondii and Appropriate Vaccine Design
- D Diagnosis and Treatment of Toxoplasmosis
- Detection of IgA anti-P30 (SAG1) Antibodies in Acquired and Congenital Toxoplasmosis
- AIDS-Associated Cerebral Toxoplasmosis: An Update on Diagnosis and Treatment
- Co-infection of Toxoplasma gondii with Other Pathogens: Pathogenicity and Chemotherapy in Animal Models
- Influence of AntimicrobialAgents on Replication and Stage Conversion of Toxoplasma gondii
- Molecular Genetic Tools for the Identification and Analysis of Drug Targets in Toxoplasma gondii
- Studies of the Effect of Various Treatments on the Viability of Toxoplasma gondii Tissue Cysts and Oocysts